Speaker Profile

PMWC PIONEER AWARD
Trailblazed the field of early cancer detection through a focus on tumor-shed DNA in bodily fluids; improved patient outcomes through development of the patient-derived xenograft (PDX) model

M.D., Professor of Oncology, Johns Hopkins U.

Biography
David Sidransky is a renowned physicianscientist whose contributions have revolutionized the field of oncology precision medicine. He has developed noninvasive liquid biopsy methods for early cancer detection and many other translational molecular approaches. Dr. Sidranskys pioneering work has focused on the identification of genetic and epigenetic alterations in cancer. He was the first to identify altered DNA in stool, urine, sputum, saliva, and blood samples for cancer detection. His research has led to the development of several diagnostics and the use of PDX models for therapeutic drug development. Dr. Sidranskys exceptional achievements have earned him numerous awards and accolades including the AACRs Rosenthal award in 2004 and team science award in 2017. He has founded and served on the board of several biotechnology companies. He authored over 600 scientific articles and 30 patents and served on distinguished editorial boards. His dedication and accumulated work continue to inspire and guide researchers around the world.


 Session Abstract – PMWC 2024 Silicon Valley

Track 4 - January 25 9.00 A.M.-4.15 P.M.


Track Chair: Laura J. van 't Veer, UCSF

  • PMWC 2024 Award Ceremony
    Pioneer Honoree: David Sidransky, Johns Hopkins
    Luminary Honorees: Helmy Eltoukhy & AmirAli Talasaz, Guardant Health
  • Utilities of Liquid Biopsy in Biomarker Testing
    - Laura Vent Veer, UCSF
  • Status Quo of Clinical Liquid Biopsy
    Chair: Helmy Eltoukhy, Guardant Health
    - Sadakatsu Ikeda, Tokyo Medical University
    - Heather Parsons, Dana-Farber Cancer Institute
    - Bruna Pellini, Moffitt Cancer Center
    - Sanjay Popat, The Royal Marsden
  • Liquid Biopsy for Health Monitoring and Disease Prevention (PANEL)
    Chair: Anne-Renee Hartman, Adela Bio
    - AmirAli Talasaz, Guardant Health
    - Heather Parsons, Dana-Farber Cancer Institute
    - Mary Pat Lancelotta, Adaptive Bio
  • Liquid Biopsy in Early Cancer Detection (PANEL)
    Chair: Tom Beer, Exact Sciences
    - Wendy Rubinstein, Cancer Screening Research Network (CSRN)
  • Keynote: Pioneering Liquid Nucleic acids Tumor Fragments in Health and Diseases
    - David Sidransky, Johns Hopkins
  • New Approaches in Liquid Biopsy (PANEL)
    Chair: Victor Velculescu, Johns Hopkins
    - David Sidransky, Johns Hopkins
    - Dan Laudau, NY Genome Center
    - Daniel De Carvalho, University of Toronto
  • Global Implications: A scalable Liquid Biopsy for HPV-related Cervical Cancer (PANEL)
    Chair: Debra Fraser-Howze, D. Fraser Associates
    - Belinda Nedjai, Wolfson Institute of Population Health
    - Elisabeth Adams, Aquarius Population Health Limited
  • PMWC Showcase
    - Sandrine Miller-Montgomery, Micronoma

×

Add Names/PO on Receipt

Apply to Speak at PMWC Silicon Valley by SEP. 28TH

The PMWC team will reply back to a suitable company/topic with an official request for talk/speaker details.

Contact Us:

Fields marked with an * are required 

Contact Us:

Fields marked with an * are required 

Discover What's Next in Precision Medicine!

Join our community today for the latest news, exclusive interviews, and unique insights from world-renowned speakers and experts


Trouble Registering

Fields marked with an * are required

Stay Tuned For More Information.

Sign up for occasional updates on upcoming conferences, news, and other information. 

Get Updates:

Submit to Speak in the PMWC Showcase

Fields marked with an * are required